Tuesday, 3 November 2009

Further information on Fragile X from a company looking for something like a cure

About Fragile X Syndrome
Fragile X Syndrome is the most common inherited form of mental impairment and the most common known cause of autism. Fragile X Syndrome is caused by a mutation of a single gene, the Fragile X mental retardation 1 (FMR1) gene, on the X chromosome. The FMR1 gene produces a protein needed for normal brain development. Individuals with Fragile X Syndrome lack this protein and, as a result, exhibit a number of behavioral and physical symptoms including mental and developmental impairment to varying degrees, attention deficit and hyperactivity, autistic behaviors, anxiety, large physical attributes, particularly of the face, and seizures. Fragile X Syndrome typically impacts boys more severely than girls, with 20% of boys also receiving a diagnosis of autism. There is no cure for Fragile X Syndrome at this time. A variety of medications and behavioral interventions are used in an attempt to address individual symptoms of the disease. Drugs currently used primarily focus on treating specific symptoms such as anxiety, or improving and controlling behavior. About Seaside Therapeutics Seaside Therapeutics is creating new drug treatments to correct or improve the course of Fragile X Syndrome, autism and other disorders of brain development. We are dedicated to translating breakthrough discoveries in neurobiology into therapeutics that improve the lives of patients and their families. For more information visit www.seasidetherapeutics.com.

No comments: